Researchers have developed an organ-on-a-chip model that simulates drug-induced muscle and kidney damage. The technology is part of a broader trend of emerging organ-on-a-chip systems, which can be used for disease modeling, drug development, and personalized medicine. The specific applications and capabilities of these systems are still being explored, with various studies and models focusing on different organs and potential uses.